Monza, Italy

Claudio Gianluca Pozzoli

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.6

ph-index = 1


Location History:

  • Monza, IT (2004 - 2015)
  • Gropello Cairoli, IT (2017)

Company Filing History:


Years Active: 2004-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Claudio Gianluca Pozzoli: Innovator in Pharmaceutical Chemistry

Introduction

Claudio Gianluca Pozzoli is a notable inventor based in Monza, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the purification and synthesis of important compounds. With a total of five patents to his name, Pozzoli's work has had a considerable impact on the development of antiviral and antitumor agents.

Latest Patents

Among his latest patents is a process for the purification of melphalan. This method allows for the production of melphalan with a purity higher than 99.5%. Another significant patent involves the synthesis of nucleosides, which describes a process for preparing nucleosides, derivatives, and analogues through a coupling reaction. This process is particularly useful for creating antiviral and antitumor agents, achieving a residual tin content lower than 300 ppm.

Career Highlights

Claudio has worked with several companies throughout his career, including Farmabios S.p.a. and Euticals Prime European Therapeutical Spa. His expertise in pharmaceutical chemistry has enabled him to develop innovative processes that enhance the efficacy and safety of important medical compounds.

Collaborations

Throughout his career, Pozzoli has collaborated with notable colleagues such as Valentina Canevari and Matteo Curti. These collaborations have further enriched his research and development efforts in the pharmaceutical field.

Conclusion

Claudio Gianluca Pozzoli is a distinguished inventor whose work in pharmaceutical chemistry continues to influence the development of critical medical treatments. His innovative patents and collaborations highlight his commitment to advancing the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…